Summary of Product Characteristics​

Summary of Product Characteristics

 

Reference

  1. IBRANCE® Summary of Product Characteristics.

PP-IBR-IRL-0288
Date of preparation: March 2020

▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 of the SmPC for how to report adverse reactions.